SYRE Financials
Spyre Therapeutics Inc - Financial statements & key metrics
Stock Price
$73.01
Market Cap
$5.94B
EPS
$-1.98
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-208.02M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$608.48M
Total Liabilities
$90.68M
Shareholders Equity
-
Cash & Equivalents
$89.42M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-157.41M
CapEx
-
Free Cash Flow
-
Profitability Metrics
ROE
-0.3%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is SYRE revenue?
View SYRE's income statement for detailed revenue data.
Is SYRE profitable?
SYRE reported a loss of $208.02M in the most recent quarter.
What is SYRE market cap?
SYRE has a market capitalization of $5.94B, making it a mid-cap stock.
Does SYRE have debt?
View SYRE's balance sheet for debt information.
What is SYRE cash flow?
Cash flow data is available in the full financial statements.